Athira Pharma Inc (NAS:ATHA)
$ 0.5499 0.0114 (2.12%) Market Cap: 21.26 Mil Enterprise Value: -46.72 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 36/100

Q4 2021 Athira Pharma Inc Earnings Call Transcript

Mar 24, 2022 / 08:30PM GMT
Release Date Price: $11.87 (+5.60%)
Operator

Welcome to Athira Pharma's conference call to discuss its full-year 2021 financial results and business update. At this time, all participants are in a listen-only mode. Following the conclusion of the prepared remarks, we will conduct a question-and-answer session and instructions will follow at that time. This conference call is being recorded today, March 24, 2022.

I would like to turn the conference call over to Julie Rathbun, Head of Investor and Public Relations at Athira Pharma.

Julie Rathbun
Athira Pharma, Inc. - Head of IR

Thank you, operator. Following the close of the US financial market today, we issued full-year 2021 financial results and recent business updates. This press release can be found on the investors section of our website.

Before we begin, I'd like to remind you that during this call, management will make forward-looking statements, which may include statements about research and clinical development plans and timelines and results of operations, the timing of and results from clinical trials and preclinical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot